Abdominal Abscess
Conditions
Keywords
Peritonitis, Community-Acquired Infections, Cross Infection
Brief summary
The primary objective of this study is to compare the safety and efficacy of an experimental antibiotic to a marketed antibiotic in the treatment of Chinese subjects with complicated intra-abdominal infections. \<br /\>
Interventions
DRUGtigecycline
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
· Hospitalized male or female subjects over 18 years of age
Exclusion criteria
· Subjects with any concomitant condition that, in the opinion of the investigator, would preclude an evaluation of a response or make it unlikely that the contemplated course of therapy or follow-up visits could be completed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical response for all microbiologically evaluable and microbiologically modified intent-to-treat subjects at the test-of-cure visit | — |
Secondary
| Measure | Time frame |
|---|---|
| Microbiological response at the subject and pathogen level and evaluation of microbiological data, such as decreased susceptibility, response rates by baseline isolate and minimal inhibitory concentration (MIC) values and susceptibility data by isolate | — |
Countries
China
Outcome results
None listed